NCT05699096

Brief Summary

Perfluorohexyloctaneis Essential for Repositioning Giant Retinal Breaks and Can be Used for Removal of Subretinal Fluid as Well as Stabilization of the Retina to Offset

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
2mo left

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress92%
Sep 2024Jul 2026

First Submitted

Initial submission to the registry

January 15, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 26, 2023

Completed
1.6 years until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Expected
Last Updated

July 3, 2024

Status Verified

June 1, 2024

Enrollment Period

10 months

First QC Date

January 15, 2023

Last Update Submit

June 30, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • flat the detached retina and displace the underneath fluids anteriorly

    the effect of Perfluorooctyl Bromide on the retina ,under ophthalmic microscope check the flatted retina

    Base line

Study Arms (1)

eye surgery ,Vitreoretinal Surgery and Related Ocular Inflammation

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

primary care clinic

You may qualify if:

  • \- Is 20 years or older Has been diagnosed with Keratoconus; Has no other active ocular disease; Is not pregnant or nursing;

You may not qualify if:

  • Is under the age of 20 Has best corrected visual acuity outside 20/400; Pregnant or nursing at the time of enrollment in the study;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Girgis Boules

Cairo, Kubri EL Kubba, 11711, Egypt

RECRUITING

MeSH Terms

Conditions

Retinal Diseases

Condition Hierarchy (Ancestors)

Eye Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2023

First Posted

January 26, 2023

Study Start

September 1, 2024

Primary Completion

July 1, 2025

Study Completion (Estimated)

July 1, 2026

Last Updated

July 3, 2024

Record last verified: 2024-06

Locations